StockData
BIOMOTCPharmaceutical PreparationsFiscal year ends December 31

BIOMOLECULAR LIFE HOLDINGS, INC.

Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Nov 19, 2015
$0.79−0.02 (-2.47%)

Close on Oct 19, 2026

Market cap
$67.51M
P/E (TTM)
–
Dividend yield
–

BIOMOLECULAR LIFE HOLDINGS, INC. revenue by segment

No segment breakdown reported

Biomolecular Life does not break out revenue by segment, region or product in the tagged data of its filings for this period type.